Previously, we found that monoamine oxidase A (MAOA), the major NE/E degrading enzyme, is significantly downregulated in HCC, and conducts an inhibitory function in NE-induced HCC metastasis via blocking β-AR signaling and EGFR transactivation (Li et al., 2014). Here, MAOA is linked to hepatocellular carcinoma.